RCRebecca Canneto

Rebecca Canneto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rebecca Canneto has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI in High-Frequency Micro-Ultrasound: Advancing Prostate Imaging from Segmentation to Cancer Detection

    by Ludovica Cella, Marco Paciotti, Pier Paolo Avolio, Vittorio Fasulo, Andrea Piccolini, Rebecca Canneto, Giacomo Cavadini, Luca Di Stefano, Alberto Saita, Paolo Casale, et al.

    Background/Objective: High-frequency micro-ultrasound (micro-US) offers real-time, high-resolution imaging for prostate cancer. Although artificial intelligence (AI) has shown potential in enhancing micro-US interpretation, a comprehensive review of this emerging field is currently missing. This review synthesizes current evidence on AI applied to ExactVu 29 MHz micro-US for prostate cancer. Methods: PubMed/MEDLINE, Embase, Scopus, Web of Science and the Cochrane Library were searched up to December 2025. Studies were included if they applied machine learning or deep learning directly to 29 MHz micro-US data and reported quantitative performance metrics. Results: Ten studies met the inclusion criteria: six on prostate cancer detection, three on prostate segmentation and one on micro-US–histopathology registration. Detection models ranged from classical quantitative ultrasound machine learning to deep architectures using self-supervision, transformers, multiple-instance learning, ensemble calibration and 3D segmentation-based pipelines. Among core-level models for clinically significant cancer, area under the receiver operating characteristic curve (AUROC) values clustered around 0.76–0.81; one lesion-level framework reported an AUROC of 0.92, though at a non-comparable analytical unit. Segmentation studies achieved accurate prostate delineation (Dice similarity coefficient ≈ 0.94), and a single study demonstrated high-precision 3D registration to whole-mount histopathology (Dice similarity coefficient 0.97 and landmark error < 3 mm). All studies evaluated AI on previously acquired data, without real-time clinical implementation. Conclusions: AI for micro-US shows promising and reproducible early results across detection, segmentation and registration, but evidence is still limited. In view of the potential of AI to optimize micro-US utilization and its related advantages, additional efforts are warranted to achieve clinical adoption.